STOCK TITAN

Ceribell (CBLL) CFO sells 34,502 shares near $25 under 10b5-1 plan

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Ceribell, Inc. (CBLL) reported insider transactions by Chief Financial Officer Scott Blumberg on August 18–19, 2026. Blumberg exercised stock options covering 34,502 shares of common stock at exercise prices of $4.70 and $9.41 per share, then sold 34,502 shares of common stock at prices around $25 per share, including a weighted average sale price of $25.03. All transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on December 12, 2025.

Positive

  • None.

Negative

  • None.
Insider Blumberg Scott
Role Chief Financial Officer
Sold 34,502 shs ($864K)
Approx. gross sale proceeds $864K
Approx. exercise cost $292K
Approx. pre-tax spread $571K
Type Security Shares Price Value
Exercise Stock Option (Right to Buy) F1, F4 6,179 $0.00 $0.00
Exercise Stock Option (Right to Buy) F1, F5 27,333 $0.00 $0.00
Exercise Common Stock F1 6,179 $4.70 $29K
Exercise Common Stock F1 27,333 $9.41 $257K
Sale Common Stock F1, F3 33,512 $25.03 $839K
Exercise Stock Option (Right to Buy) F1, F4 690 $0.00 $0.00
Exercise Stock Option (Right to Buy) F1, F5 300 $0.00 $0.00
Exercise Common Stock F1, F2 690 $4.70 $3K
Exercise Common Stock F1 300 $9.41 $3K
Sale Common Stock F1 990 $25.00 $25K
Holdings After Transaction: Stock Option (Right to Buy) — 90,524 shares (Direct); Common Stock — 148,121 shares (Direct)
Footnotes (5)
  1. F1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025.
  2. F2. Includes 438 shares acquired under the Issuer's Employee Stock Purchase Plan on July 31, 2026.
  3. F3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25 to $25.16, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased or sold, as applicable, at each separate price within the ranges set forth in this footnote.
  4. F4. The option vests with respect to 1/48 of the shares subject thereto on each monthly anniversary of April 1, 2023, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.
  5. F5. The stock option is fully vested and currently exercisable.
Options exercised 34,502 shares of Common Stock Total underlying shares from option exercises (code M) on August 18–19, 2026
Shares sold 34,502 shares of Common Stock Aggregate non-derivative sales (code S) on August 18–19, 2026
Option exercise price $4.70 per share Exercise price for portions of the stock options exercised into common stock
Option exercise price $9.41 per share Exercise price for additional stock options exercised into common stock
Weighted average sale price $25.03 per share Weighted average price for 33,512 shares sold in multiple trades ranging $25.00–$25.16
10b5-1 plan adoption date December 12, 2025 Date the Rule 10b5-1 trading plan governing these transactions was adopted
ESPP shares 438 shares Shares acquired under the Employee Stock Purchase Plan on July 31, 2026, included in holdings
Rule 10b5-1 trading plan regulatory
"transactions were effected pursuant to a Rule 10b5-1 trading plan adopted"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average price financial
"The price reported in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
Employee Stock Purchase Plan financial
"Includes 438 shares acquired under the Issuer's Employee Stock Purchase Plan"
An employee stock purchase plan is a company program that lets workers buy shares through small payroll deductions, often at a discount to the market price and after a set offering period. Think of it like a workplace savings plan that turns into ownership: it encourages employees to share in the company’s success and can create predictable buying or selling of stock that investors watch because it affects supply, demand and employee incentives.
vests financial
"The option vests with respect to 1/48 of the shares subject thereto"
stock option financial
"The stock option is fully vested and currently exercisable."
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.

FAQ

What insider transactions did Ceribell (CBLL) report for CFO Scott Blumberg?

Ceribell reported that CFO Scott Blumberg exercised stock options for 34,502 shares of common stock and sold 34,502 shares of common stock on August 18–19, 2026, in a series of option exercises and open-market sales.

How many Ceribell (CBLL) shares did the CFO sell and at what prices?

The CFO sold a total of 34,502 shares of Ceribell common stock. Reported sale prices included $25.00 per share for 990 shares and a $25.03 weighted average price for 33,512 shares, with individual trades ranging from $25.00 to $25.16 per share.

What stock options did the Ceribell (CBLL) CFO exercise in this Form 4?

Scott Blumberg exercised stock options for 34,502 shares of Ceribell common stock, consisting of options with exercise prices of $4.70 per share and $9.41 per share, with expiration dates in 2033 and 2034, respectively.

Were the Ceribell (CBLL) insider transactions under a Rule 10b5-1 plan?

Yes. A footnote states that all transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2025.

Did the Ceribell (CBLL) filing mention any Employee Stock Purchase Plan activity?

Yes. A footnote notes that holdings include 438 shares acquired under Ceribell’s Employee Stock Purchase Plan on July 31, 2026, though this is contextual and not itself listed as a separate transaction row.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Blumberg Scott

(Last)(First)(Middle)
C/O CERIBELL, INC.
360 N. PASTORIA AVENUE

(Street)
SUNNYVALE CALIFORNIA 94085

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Ceribell, Inc. [ CBLL ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Financial Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/18/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock08/18/2026M(1)690A$4.7148,811(2)D
Common Stock08/18/2026M(1)300A$9.41149,111D
Common Stock08/18/2026S(1)990D$25148,121D
Common Stock08/19/2026M(1)6,179A$4.7154,300D
Common Stock08/19/2026M(1)27,333A$9.41181,633D
Common Stock08/19/2026S(1)33,512D$25.03(3)148,121D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy)$4.708/18/2026M(1)690 (4)02/16/2033Common Stock690$043,403D
Stock Option (Right to Buy)$9.4108/18/2026M(1)300 (5)04/23/2034Common Stock300$080,633D
Stock Option (Right to Buy)$4.708/19/2026M(1)6,179 (4)02/16/2033Common Stock6,179$037,224D
Stock Option (Right to Buy)$9.4108/19/2026M(1)27,333 (5)04/23/2034Common Stock27,333$053,300D
Explanation of Responses:
1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025.
2. Includes 438 shares acquired under the Issuer's Employee Stock Purchase Plan on July 31, 2026.
3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25 to $25.16, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased or sold, as applicable, at each separate price within the ranges set forth in this footnote.
4. The option vests with respect to 1/48 of the shares subject thereto on each monthly anniversary of April 1, 2023, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.
5. The stock option is fully vested and currently exercisable.
/s/ Louisa Daniels, Attorney-in-Fact for Scott Blumberg08/20/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)